In cell studies involving SH-SY5Y cells transfected with the Swedish mutant APP695, and in the AD transgenic PDAPP mouse model, NSAIDs demonstrated their ability to lower Aβ42 formation and inhibit RhoA activity. This evidence concerns the gene RHOA and Alzheimer disease.